| AFM | Atomic force microscopy |
| AMD | Age Macular Degeneration |
| Anti-VEGFs | Anti-vascular endothelial growth factors agents |
| ATR–FTIR | Fourier transform infrared spectral analysis |
| β-CD | β-cyclodextrin |
| CCB | Celecoxib |
| CCCs | Chitosan coated cubosomes |
| CCLs | chitosan coated liposomes |
| CDs | Cyclodextrins |
| CMCS | Carboxymethyl chitosan |
| CNV | Choroidal neovascularization (CNV) |
| Cs | Chitosan |
| CSO | Chitosan oligosaccharide |
| CVS | Chitosan oligosaccharide-valylvaline-steric acid |
| DEX | Dexamethasone |
| DR | Diabetic Retinopathy |
| DDS | Drug Delivery System |
| %EE | % Entrapment Efficiency |
| FITC | Fluorescein isothiocyanate isomer |
| GIT | Gastrointestinal tract |
| HConEpiC | Human conjunctival epithelial primary cells |
| HCEpiC | Human Corneal Epithelial Primary Cells |
| HP-β-CD | Hydroxypropyl β-cyclodextrin |
| HPMC | Hydroxypropyl methylcellulose |
| IVT | Intravitreal |
| LDH | Inorganic materials of hydroxide |
| MEs | microemulsions |
| MLVs | multilamellar vesicles |
| NF | Nepafenac |
| NLCs | Nanostructured lipid carriers |
| NMR | Nuclear magnetic resonance |
| OC-40 | Octoxynol-40 |
| OcDD | Ocular drug delivery |
| PDT | Photodynamic therapy |
| PEG | Poly (ethylene glycol) |
| PepT-1 | Peptide transporter-1 |
| PGF | Placental Growth Factors |
| P-gp | P-glycoprotein |
| PLGA | poly (lactic-co-glycolic acid) |
| PDS | port delivery system |
| PS | Particle size |
| PSEDs | Posterior segment eye diseases |
| PVA | Polyvinyl alcohol |
| PVA-R | Polyvinyl alcohol derivatives bearing a hydrophobic anchor at the terminate molecule |
| SA | Steric acid |
| TA | Triamcinolone aetonide |
| TER | Transepithelial electrical resistance |
| TPP | Sodium tripolyphosphate |
| ULVs | Unilamellar vesicles |
| VEGF | Vascular Endothelial Growth Factors |
| VV | Valyl valine |
| ZP | Zeta potential |